Showing 1 – 20 of 205
SORT: Best Match Most Recent Oldest
VIEW: Basic | Expanded
  • Original Contribution June 08, 2011

    Saundra S. Buys, MD; Edward Partridge, MD; Amanda Black, PhD, MPH; Christine C. Johnson, PhD, MPH; Lois Lamerato, PhD; Claudine Isaacs, MD; Douglas J. Reding, MD, MPH; Robert T. Greenlee, PhD, MPH; Lance A. Yokochi, MD, PhD; Bruce Kessel, MD; E. David Crawford, MD; Timothy R. Church, PhD, MS; Gerald L. Andriole, MD; Joel L. Weissfeld, MD, MPH; Mona N. Fouad, MD; David Chia, PhD; Barbara O’Brien, MPH; Lawrence R. Ragard, MD; Jonathan D. Clapp; Joshua M. Rathmell; Thomas L. Riley, BS; Patricia Hartge, ScD, MA; Paul F. Pinsky, PhD; Claire S. Zhu, PhD; Grant Izmirlian, PhD; Barnett S. Kramer, MD; Anthony B. Miller, MD; Jian-Lun Xu, PhD; Philip C. Prorok, PhD; John K. Gohagan, PhD; Christine D. Berg, MD; for the PLCO Project Team
    TOPICS: lung, cancer, mortality, prostate, ovarian cancer, cancer screening

    JAMA. 2011; 305(22):2295-2303. doi: 10.1001/jama.2011.766

    Includes: Supplemental Content
  • Original Investigation April 19, 2016

    Antoni Ribas, MD, PhD; Omid Hamid, MD; Adil Daud, MD; F. Stephen Hodi, MD; Jedd D. Wolchok, MD, PhD; Richard Kefford, MD, PhD; Anthony M. Joshua, MBBS, PhD; Amita Patnaik, MD; Wen-Jen Hwu, MD, PhD; Jeffrey S. Weber, MD, PhD; Tara C. Gangadhar, MD; Peter Hersey, MD, PhD; Roxana Dronca, MD; Richard W. Joseph, MD; Hassane Zarour, MD; Bartosz Chmielowski, MD, PhD; Donald P. Lawrence, MD; Alain Algazi, MD; Naiyer A. Rizvi, MD; Brianna Hoffner, BA, RN, MSN; Christine Mateus, MD; Kevin Gergich, MA; Jill A. Lindia, MS; Maxine Giannotti, BS; Xiaoyun Nicole Li, PhD; Scot Ebbinghaus, MD; S. Peter Kang, MD; Caroline Robert, MD, PhD
    TOPICS: melanoma, neoplasms, toxic effect, pembrolizumab, immune checkpoint inhibitors

    JAMA. 2016; 315(15):1600-1609. doi: 10.1001/jama.2016.4059

    Includes: Multimedia, Supplemental Content